期刊文献+

HBcAg肽特异性CD8^+T细胞抑制乙型肝炎病毒的体外实验研究 被引量:1

HBcAg-specific CD8^+T Cells Inhibit HBV Replication in vitro
下载PDF
导出
摘要 目的观察HBV感染者的HBcAg肽特异性CD8+T细胞体外抑制乙型肝炎病毒(HBV)的作用和探讨非溶细胞机制清除病毒的效应分子。方法以HepG2.2.15细胞为靶细胞。用HLA-A匹配的HBcAg肽特异性CD8+T细胞克隆(效应细胞)与靶细胞(效靶比例1∶50)共同培养,于24h、48h和72h收集培养上清,通过检测其中HBV产物的变化,观察CD8+T克隆对HBV的抑制作用。用抗体中和法观察CD8+T细胞分泌的IFN-γ被封闭后HBV抑制的变化。结果 HBV特异性CD8+T克隆与靶细胞共育后,培养上清可检出高水平IFN-γ。共育后对HBsAg、HBeAg和HBV-DNA的最高抑制率分别为54.55%、50.36%和74.55%,均在72h。IFN-γ被抗体封闭后,对HBV DNA的抑制率显著下降,24h和48h分别为6.22%和17.48%。细胞毒活性最高见于24h,15.66%。结论①病毒特异性CD8+T细胞对靶细胞中HBV的清除既有溶细胞机制,也有非溶细胞机制参与;②IFN-γ是非溶细胞机制清除病毒的主要效应分子。 Objective To investigate the effects of HBcAg - specific CD8^ + T cells on inhibiting HBV replication in vitro,and to search the cytokine of noncytolytic mechanisms in viral clearance. Methods By the method of coculture of HepG2.2. 15 cell ( target cells) with HLA - A2 matched HBcAg - specific CD8^ + T cell clone ( effector cells) at E : T ratios of 1 : 50, and monitoring HBV production (HBsAg,HBeAg, and HBV- DNA)in coculture supernatants at 24h,48h and 72h, the percentage of decrease in HBV replication level was observed. Furthermore, blocking experiment with neutralizing mAbs to IFN -γ was performed to evaluate the effect of this cyto- kine. Results CD8 ^+ T clone produced high levels of IFN - γ following coculture with 2.2.15 ceils. HBsAg,HBeAg and HBV - DNA in cocuhure supernatants were significantly reduced, and the greatest effect was observed at 72h by 54.55 % ,50.36% and 74.55% , respectively. The reduction of HBV DNA was decreased followed by using neutralizing mAbs to IFN - γ. The maximum activity of cytotoxicity of target ceils was at 24h by 15.66%. Conclusion ①HBV - specific CD8^+ T cells inhibit HBV replication by cytolytic and noncytolytic mechanisms.②The effect of noncytolytic mechanisms is mainly mediated by IFN - γ.
出处 《医学研究杂志》 2010年第5期24-27,共4页 Journal of Medical Research
基金 国家自然科学基金资助项目(30671929)
关键词 乙型肝炎病毒 特异性CD8+T细胞 干扰素-Γ HEPG2.2.15细胞 Hepatitis B virus Specific CD8 ^ T cells IFN -γ HepG2.2.15 cells
  • 相关文献

参考文献13

  • 1王海燕,贺永文,朱传武,钱峰,李明,罗湘蓉,常建国,张雪华.慢性乙型肝炎患者肝组织穿孔素表达的临床意义[J].世界华人消化杂志,2006,14(22):2207-2210. 被引量:7
  • 2李明,朱传武,钱峰,王海燕,诸葛洪祥.慢性乙型肝炎患者外周血单个核细胞穿孔素表达与干扰素抗病毒疗效的关系[J].中华肝脏病杂志,2006,14(10):729-731. 被引量:8
  • 3Nair S, Perrillo RP. Serum alanine aminotransferase flares during interferon treatment of chronic hepatitis B: is sustained clearance of HBV DNA dependent on levels of pretreatment viremia? Hepatology,2001, 34:1021 - 1026.
  • 4Ganem D, Prince AM. Hepatitis B Virus Infection - Natural History and Clinical Consequences. N Engl J Med, 2004, 350( 11 ) :2719 - 2720.
  • 5Guidotti LG,Ando K, Hobbs MV, et al. Cytotoxic T lymphocytes inhibit hepatitis B vires gene expression by a noncytolytic mechanism in transgenic mice. Proc Nati Acad Sci, 1994,91 (9) :3764 -3768.
  • 6Thimme R, Wieland S, Steiger C, et al. CD8^+ T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol ,2003,77 ( 1 ) :68 - 76.
  • 7Guidotti LG, Roehford R, Chung J,et al. Viral clearance without destruction of infected ceils during acute HBV infection. Science, 1999,284(5415):825 -829.
  • 8郑纪山,何长伦,王寿明,张益红,唐雨德,戴宇东.急性乙型肝炎HBcAg特异性CTL克隆建立及初步分析[J].传染病信息,2009,22(4):200-202. 被引量:3
  • 9Bertoni R, Sidney J, Fowler P,et al. Human histocompatibility leukocyte antigen - binding supermotifs predict broadly cross - reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J Clin Invest, 1997, 100(3):503-513.
  • 10Sells MA,Chen ML, Acs G. Production of hepatitis B virus particles in Hep G2 ceils transfected with cloned hepatitis B virus DNA. Proc Nati Acad Sci, 1987, 84(4) :1005 - 1009.

二级参考文献25

  • 1Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 2卢晓敏,王文远,孙成刚.HLA-A基因频率与HBV感染的相关性研究[J].临床肝胆病杂志,2006,22(2):91-92. 被引量:5
  • 3李晓东,徐东平,成军,钟彦伟,刘妍,董菁,王琳,张玲霞.中国人群流行的乙型肝炎病毒特异性CTL表位特点分析[J].解放军医学杂志,2006,31(8):775-777. 被引量:12
  • 4Iannacone M, Sitia G, Ruggeri ZM, et al. HBV pathogenesis in animal models: recent advances on the role of platelets[J]. J Hepatol, 2007, 46(4):719-726.
  • 5Thimme R, Wieland S, Steiger C, et al. CD8^+ T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection[J]. J Virol, 2003, 77(1):68-76.
  • 6Chun E, Lee J, Cheong HS, et al. Tumor eradication by hepatitis B virus X antigen-specific CD8^+ T cells in xenografted nude mice[J]. J Immunol, 2003, 170(3):1183-1190.
  • 7McClary H, Koch R, Chisari FV, et al. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines [J]. J Virol, 2000, 74(5):2255-2264.
  • 8Wallen H, Thompson JA, Reilly JZ, et al. Fludarabine modulates immune response and extends in vivo survival of adoptively transferred CD8 T cells in patients with metastatic melanoma[J]. PLoS One, 2009, 4(3): e4749.
  • 9Tsai SL, Chen MH, Yeh CT, et al. Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8^+ cytotoxic T lymphocytes[J]. J Clin Invest, 1996, 97(2):577-584.
  • 10Bertoni R, Sidney J, Fowler P, et al. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly crossreactive cytotoxic T lymphocyte responses in patients with acute hepatitis[J]. J Clin Invest, 1997, 100(3):503-513.

共引文献13

同被引文献19

  • 1Liang Q,Jiao Y,Zhang T,et al. Double negative (DN) [CD3+CD4-CD8-] T cells correlate with disease progression during HIV infection. Immunol Invest,2013,42(5):431-437.
  • 2Nakamoto Y,Kaneko S. Mechanisms of viral hepatitis induced liver injury. Curr Mol Med,2003,3(6):537-544.
  • 3Acquisto FD,Crompton T. CD3+CD4-CD8- (double negative) T cells:Saviours or villains of the immune response. Biochem Pharmacol,2011,82(4):333-340.
  • 4Juvet SC,Zhang L. Double negative regulatory T cells in transplantation and directions. J Mol Cell progress and future Biol, 2012,4( 1 ):48-58.
  • 5Zhang ZX,Yang L,Young KJ,et al. Identification of a previ- ously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat Med,2000,6(7):782-789.
  • 6Zhang ZX,Ma Y,Wang H,et al. Double-negative T cells, acti- vated by xenoantigen,lyse autologous B and T cells using a perforin/granzyme-dependent,Fas-Fas ligand-independent path- way. J Immunol,2006,177(10):6920-6929.
  • 7Wang X,Yan W,Lu Y,et al. CD4-CD8+T cells contribute to the persistence of viral hepatitis by striking a delicate balance in immune modulation. Call Immunol, 2012,280( 1 ):76-84.
  • 8李文,屠涌涛,何敏儿.乙型肝炎病毒携带者外周血T淋巴细胞亚群测定[J].实用肝脏病杂志,1999,4(2):91-92. 被引量:1
  • 9唐祖明,张胜子,常静霞,郑纪山.CD8^+T淋巴细胞非溶细胞功能抑制HepG2.2.15细胞表达HBV的实验研究[J].临床医学工程,2010,17(2):1-3. 被引量:1
  • 10刘波,李军,韩亚萍,刘源,曹阳,黄祖瑚.急性乙型肝炎外周血淋巴细胞亚群动态分析[J].江苏医药,2010,36(6):621-624. 被引量:8

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部